Hotchkis & Wiley Capital Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-117,620
| Closed | -$6.3M | – | 527 |
|
|
2023
Q4 | $6.3M | Buy |
117,620
+26,450
| +29% | +$1.42M | 0.02% | 363 |
|
|
2023
Q3 | $5.34M | Sell |
91,170
-24,350
| -21% | -$1.43M | 0.02% | 352 |
|
|
2023
Q2 | $7.28M | Sell |
115,520
-2,510
| -2% | -$158K | 0.03% | 289 |
|
|
2023
Q1 | $7.42M | Buy |
118,030
+4,700
| +4% | +$296K | 0.03% | 248 |
|
|
2022
Q4 | $6.03M | Buy |
113,330
+43,410
| +62% | +$2.31M | 0.02% | 291 |
|
|
2022
Q3 | $3.92M | Sell |
69,920
-28,190
| -29% | -$1.58M | 0.02% | 368 |
|
|
2022
Q2 | $7.1M | Buy |
98,110
+11,340
| +13% | +$821K | 0.03% | 236 |
|
|
2022
Q1 | $6.89M | Buy |
86,770
+15,528
| +22% | +$1.23M | 0.02% | 292 |
|
|
2021
Q4 | $7.21M | Sell |
71,242
-2,600
| -4% | -$263K | 0.02% | 259 |
|
|
2021
Q3 | $6.81M | Buy |
73,842
+4,880
| +7% | +$450K | 0.02% | 255 |
|
|
2021
Q2 | $7.06M | Buy |
68,962
+3,400
| +5% | +$348K | 0.02% | 254 |
|
|
2021
Q1 | $6.4M | Sell |
65,562
-2,398
| -4% | -$234K | 0.02% | 266 |
|
|
2020
Q4 | $5.24M | Buy |
67,960
+34,540
| +103% | +$2.66M | 0.02% | 259 |
|
|
2020
Q3 | $2.46M | Sell |
33,420
-23,750
| -42% | -$1.75M | 0.01% | 339 |
|
|
2020
Q2 | $4.2M | Sell |
57,170
-19,310
| -25% | -$1.42M | 0.02% | 235 |
|
|
2020
Q1 | $4.42M | Sell |
76,480
-17,520
| -19% | -$1.01M | 0.02% | 162 |
|
|
2019
Q4 | $7.38M | Buy |
94,000
+8,510
| +10% | +$668K | 0.03% | 157 |
|
|
2019
Q3 | $5.85M | Buy |
85,490
+14,660
| +21% | +$1M | 0.02% | 162 |
|
|
2019
Q2 | $5.63M | Buy |
+70,830
| New | +$5.63M | 0.02% | 192 |
|
|
2018
Q2 | – | Sell |
-12,312
| Closed | -$1.06M | – | 531 |
|
|
2018
Q1 | $1.06M | Hold |
12,312
| – | – | ﹤0.01% | 315 |
|
|
2017
Q4 | $912K | Buy |
+12,312
| New | +$912K | ﹤0.01% | 320 |
|